Tocilizumab for covid-19

Full descriptor

Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

Details

Code

Q0249

Short descriptor

Tocilizumab for covid-19

Code set

HCPCS Level II

Release

July 2026

Status

Active

Added

Jun 24 2021

Nearby codes

Code sets are published in blocks, so neighbours are usually related.